Insider grant at Zeo ScientifiX (ZEOX) of 175K restricted shares stock

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. reported an insider equity award for its CEO, CFO and director Ian T. Bothwell. On 01/14/2026, he received 175,000 shares of common stock at a price of $0 per share as a grant of restricted stock under the company’s 2021 Equity Incentive Plan. These shares vest in two equal parts, with 50% vesting on the 8th month anniversary of the grant date and the remaining 50% vesting on the 12th month anniversary. Following this transaction, Bothwell beneficially owned 915,094 shares of Zeo ScientifiX common stock held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOTHWELL IAN T

(Last) (First) (Middle)

3321 COLLEGE AVENUE

SUITE 246

(Street)

DAVIE FL 33314

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zeo ScientifiX, Inc. [ ZEOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & CFO

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/14/2026		A(1)		175,000	A	$0	915,094	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The shares vest 50% on the 8th month anniversary of the grant date and the remaining 50% on the 12th month anniversary.

	/s/ Ian T. Bothwell	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zeo ScientifiX (ZEOX) report for Ian T. Bothwell?

The company reported that CEO, CFO and director Ian T. Bothwell received a grant of 175,000 restricted shares of Zeo ScientifiX common stock on 01/14/2026 at a price of $0 per share.

How do the 175,000 restricted Zeo ScientifiX (ZEOX) shares vest for Ian T. Bothwell?

The restricted shares vest in two tranches: 50% of the grant vests on the 8th month anniversary of the grant date, and the remaining 50% vests on the 12th month anniversary of the grant date.

Under what plan were the new Zeo ScientifiX (ZEOX) shares granted to Ian T. Bothwell?

The 175,000 restricted shares were granted under Zeo ScientifiX’s 2021 Equity Incentive Plan, referred to as the "2021 Plan" in the filing.

How many Zeo ScientifiX (ZEOX) shares does Ian T. Bothwell own after this transaction?

After the reported grant, Ian T. Bothwell beneficially owned 915,094 shares of Zeo ScientifiX common stock, held with direct ownership.

What is Ian T. Bothwell’s role and ownership status at Zeo ScientifiX (ZEOX)?

Ian T. Bothwell is listed as a Director, CEO & CFO, and a 10% Owner of Zeo ScientifiX, Inc. in the Form 4.

Was the reported Zeo ScientifiX (ZEOX) transaction a purchase or a grant?

The transaction code is "A", and the filing explains it represents a grant of restricted shares under the 2021 Equity Incentive Plan, rather than an open-market purchase.